• Poster

A Quality-Adjusted Time Without Symptoms or Toxicity (Q-TWiST) AnalysisComparing First-Line Therapy With Lapatinib Plus Paclitaxel Versus Paclitaxel Alone for Patients With HER2+ Metastatic Breast Cancer (MBC)

Citation

Sherrill, B., Di Leo, A., Amonkar, M., Koehler, M., & Arbushites, M. (2008, December). A Quality-Adjusted Time Without Symptoms or Toxicity (Q-TWiST) Analysis Comparing First-Line Therapy With Lapatinib Plus Paclitaxel Versus Paclitaxel Alone for Patients With HER2+ Metastatic Breast Cancer (MBC). Presented at 2008 San Antonio Breast Cancer Symposium (SABCS), .

Abstract